Bio-Techne soars on $11.3 billion buyout deal
BUZZ-Bio-Techne soars on $11.3 billion buyout deal ** Shares of life sciences firm Bio-Techne TECH.O rise 21.8% to $71.73 premarket
** Merck KGaA MRCG.DE says it will buy Bio-Techne for $73 per share in cash, representing a total enterprise value of about $11.3 billion
** The offer price represents a 24% premium on TECH's last close
** Merck says the acquisition will be funded through a combination of existing cash and proceeds from new debt
** Up to last close, TECH mostly flat YTD
(Reporting by Christy Santhosh)
Recent news on Merck KGaA
See all newsUS stocks weekly: AI reality
US stocks weekly: AI reality
Brief: Bio-Techne Co Will Be Required To Pay To Merck KGaA Termination Fee Equal To $230.5 Million If Deal Terminated Under Certain Circumstances - SEC Filing
Press Digest: Financial Times - June 26
US STOCKS-Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook